Optimism turns to concern as Cann Group battles financial uncertainty by Steve Jones March 7, 2024March 7, 2024 With its shares suspended from the ASX amid auditor concern over its ability to keep trading, […]
German legalisation set to ‘open up opportunities’ for Australian firms by Steve Jones February 29, 2024July 16, 2024
No imported products tested since new GMP rules came into force, TGA admits, as MCIA calls for meeting by Steve Jones February 29, 2024February 29, 2024
Industry in the spotlight as regulators unite to explore rise in prescriptions by Steve Jones February 22, 2024February 22, 2024
AMCA and MCIA announce plans to present ‘unified voice’ to government by Martin Lane February 14, 2024July 16, 2024
Australia ‘watching closely’ as Israel launches Canada anti-dumping probe by Steve Jones February 8, 2024February 8, 2024
Cann Group delivers ‘modest’ growth as imports continue to frustrate by Steve Jones February 1, 2024February 1, 2024
Company news: Cann Global; Cann Group; InhaleRx; AusCann; Wellnex Life; Neurotech; MGC Pharma; Stenocare by Martin Lane December 4, 2023April 30, 2024
Peter Crock steps down as MCIA chair, replaced by Peter Koetsier by Martin Lane November 15, 2023April 30, 2024
